HOME Top Market Reports Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper) & Mobility (Mobile, Stationary) - Global Forecast to 2023

Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper) & Mobility (Mobile, Stationary) - Global Forecast to 2023

By: marketsandmarkets.com
Publishing Date: July 2018
Report Code: MD 6481

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The medical exoskeleton market is projected to reach USD 571.6 million by 2023 from USD 85.7 million in 2017, at a CAGR of 37.4% during the forecast period. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.

The objectives of this study are as follows:

  • To define, describe, and forecast the medical exoskeleton market by type, component, extremity, mobility, and region
  • To provide detailed information about factors influencing market growth (drivers, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments in North America, Asia, Europe, and the Rest of the World (RoW)
  • To strategically analyze the market structure and profile key players in the global medical exoskeleton market and comprehensively analyze their core competencies
  • To track and analyze company developments such as partnerships, agreements, and collaborations; expansions; acquisitions; and product launches in the market

Drivers

Increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches

Globally, the number of people with physical disabilities is increasing majorly due to the rising geriatric population, increasing number of road accidents and severe trauma injuries, and increasing prevalence of stroke, among other factors. According to the US Census Bureau, the global elderly population is estimated to increase at a steady pace in the coming years, from 900.9 million in 2015 to 1,402.4 million by 2030, and 2,092.0 million by 2050. All major regions across the globe are witnessing a significant growth in their geriatric populations, and this trend is expected to continue in the coming years.

With the rising geriatric population, the number of people with disabilities is increasing as the elderly are more prone to conditions such as stoke and severe musculoskeletal injuries resulting from falls. The significant growth in the geriatric population thus not only indicates the presence of more potential users for medical exoskeletons but also implies that there would be a lesser number of active people to look after the elderly and disabled in the coming years. As a result, the demand for effective rehabilitation approaches, including the use of new and advanced technologies and products, is increasing across the globe. This is considered as a positive indicator for the growth of the medical exoskeleton market in all major regions.

Increasing insurance coverage for medical exoskeletons in several countries

Assistive devices are an essential part of healthcare. In several countries, many rehabilitation centers use assistive devices provided by government organizations, special agencies, insurance companies, and charitable and non-governmental organizations.

Currently, coverage for the exoskeleton technology by insurance companies is low in several countries. However, companies are focusing on framing policies and entering into strategic collaborations and agreements with various public and private insurance providers for the reimbursement of medical exoskeleton devices. For instance, Ekso Bionics is approaching the Centers for Medicare and Medicaid Services and third-party insurers as they are expected to play an important role in the long-term commercial adoption of the Ekso GT device. Similarly, in June 2018, the ReWalk Personal 6.0 Exoskeleton System was included in the official list of medical aids (Hilfsmittelverzeichnis) by the German National Association of Statutory Health Insurance Funds (GKV-Spitzenverband), making the device officially recognized as a medical aid (according to §33 SGB V) throughout Germany. Also, in November 2017, Germany's national social accident insurance provider Deutsche Gesetzliche Unfallversicherung (DGUV) approved the rental of the ReWalk Personal exoskeleton system for qualifying beneficiaries. Such initiatives by manufacturers and insurance providers will create potential growth opportunities for the medical exoskeleton market.

Research Methodology

The study estimates the medical exoskeleton market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both the demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the medical exoskeleton market. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the medical exoskeleton market as well as to estimate the market size of various other dependent submarkets. Also, the study took into account the data shared by various associations and organizations such International Federation for Robotics (IFR), American Stroke Association (ASA), The International Journal of Robotics Research and Robotics Industries Association.

All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Medical Exoskeleton Market

To know about the assumptions considered for the study, download the pdf brochure

The medical exoskeleton market includes various players. Key players in this market include The major players in the market are Ekso Bionics Holdings, Inc. (US), ReWalk Robotics Ltd (Israel), Parker Hannifin Corp (US), Bionik Laboratories Corp (Canada), CYBERDYNE Inc. (Japan), Rex Bionics Ltd. (UK), B-TEMIA Inc. (Canada), Hocoma AG (A Subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), and ExoAtlet, O.O.O. (Russia).

Target Audience for this Report:

  • Medical exoskeleton manufacturers
  • Suppliers and distributors of medical exoskeletons
  • Hospitals, diagnostic centers, and medical colleges
  • Independent surgeons and private offices of physicians
  • Teaching hospitals and academic medical centers
  • Government bodies
  • Forums, alliances, and associations
  • Intellectual property (IP) core and licensing providers
  • Business research and consulting service providers
  • Venture capitalists

Product Launches, Enhancements, and Approvals


Month and Year

Nature of Development

Segment

Description

June 2018

Approval

Medical Exoskeleton

Parker Hannifin received approval for Indego from the Department of Veteran Affairs (US). This will help the company to further expand its market in the US.

February 2018

Launch

Robotic System

Bionic Laboratories launched the InMotion Arm interactive robotic system for clinical rehabilitation of stroke


Agreements, Collaborations, Alliances, Joint Ventures, Contracts, and Partnerships


Month and Year

Nature of Agreement

Company 1

Company 2

Description

June 2018

Agreement

B-TEMIA

Wistron Corporation (Taiwan)

To form “B-TEMIA Asia” for the marketing of Keeogo in several Asian countries. Headquartered in Singapore, B-TEMIA Asia will benefit from a significant investment from Wistron in exchange for marketing rights for Keeogo products in Asia

June 2018

Partnership

Bioness

Ottobock (Germany)

Partnered to expand distribution and access of functional electrical stimulation (FES) technologies in the European Union, the UK, Switzerland, Norway, Turkey, and India


Mergers and Acquisitions


Month & Year

Acquirer

Acquiree

Description

April 2016

Bionik

Interactive Motion Technologies, Inc (US)

To provide a wider range of rehabilitation solutions for individuals with neurological disorders living with both upper and lower body mobility challenges


Month & Year

Nature of Agreement

Company 1

Company 2/Organisation

Description

September 2016

Merger

DIH International (China)

Hocoma (Switzerland)

Hocoma merged with DIH International to provide a total solution for modern rehabilitation.


Expansions


Month & Year

Region

Description

August 2017

Italy

The company established “Villa Beretta” Centro di Riabilitazione, in Costa Masnaga (LC), Italy, as the first Center of Robotic Excellence in Europe.

November 2015

Germany

Ekso Bionics established its new regional headquarters in Freiburg, Germany, aiming to strengthen its European presence.


Scope of the Report

This report categorizes the medical exoskeleton market into the following segments and subsegments:

Medical Exoskeleton Market, By Component

  • Hardware
  • Sensors
  • Actuators
  • Power Sources
  • Control Systems
  • Other Hardware Components
  •  Software

Medical Exoskeleton Market, By Type

  • Powered Exoskeletons
  • Passive Exoskeletons

Medical Exoskeleton Market, By Extremity

  • Upper Extremity Medical Exoskeletons
  • Lower Extremity Medical Exoskeletons

Medical Exoskeleton Market, By Mobility

  • Stationary Exoskeletons
  • Mobile Exoskeletons

Medical Exoskeleton Market, By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  • Asia
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for this report.

Further Split of the RoE Medical Exoskeleton Market

  • Medical exoskeleton market size and growth rate estimates for Italy and Spain

Further Split of the Asian Medical Exoskeleton Market

  • Medical exoskeleton market size and growth rate estimates for Japan, China, and India

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 29)
    4.1 Medical Exoskeleton: Market Overview
    4.2 Medical Exoskeleton Market, By Component, 2018 vs 2023 (USD Million)
    4.3 Europe: Medical Exoskeleton Market, By Hardware Type & Country
    4.4 Medical Exoskeleton Market, By Extremity
    4.5 Medical Exoskeleton Market: Geographic Snapshot

5 Market Overview (Page No. - 33)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Number of People With Physical Disabilities and Subsequent Growth in the Demand for Effective Rehabilitation Approaches
                    5.2.1.2 Agreements and Collaborations Among Companies and Research Organizations for the Development of the Exoskeleton Technology
                    5.2.1.3 Increasing Insurance Coverage for Medical Exoskeletons in Several Countries
           5.2.2 Opportunities
                    5.2.2.1 Introduction of Soft Actuators
           5.2.3 Challenges
                    5.2.3.1 High Cost of Medical Exoskeletons

6 Medical Exoskeleton Market, By Component (Page No. - 38)
    6.1 Introduction
    6.2 Hardware
           6.2.1 Sensors
           6.2.2 Actuators
           6.2.3 Power Sources
           6.2.4 Control Systems
           6.2.5 Other Hardware Components
    6.3 Software

7 Medical Exoskeleton Market, By Type (Page No. - 45)
    7.1 Introduction
    7.2 Powered Exoskeleton
    7.3 Passive Exoskeleton

8 Medical Exoskeleton Market, By Mobility (Page No. - 49)
    8.1 Introduction
    8.2 Stationary Medical Exoskeletons
    8.3 Mobile Medical Exoskeletons

9 Medical Exoskeleton Market, By Extremity (Page No. - 53)
    9.1 Introduction
    9.2 Lower Extremity Medical Exoskeletons
    9.3 Upper Extremity Medical Exoskeletons

10 Medical Exoskeleton Market, By Region (Page No. - 57)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 UK
             10.3.2 Germany
             10.3.3 France
             10.3.4 Rest of Europe (RoE)
     10.4 Asia
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 81)
     11.1 Overview
     11.2 Market Share Ranking
     11.3 Competitive Situations and Trends
             11.3.1 Product Launches, Enhancements, and Approvals
             11.3.2 Agreements, Collaborations, Alliances, Joint Ventures, Contracts, and Partnerships
             11.3.3 Mergers and Acquisitions
             11.3.4 Expansions

12 Company Profiles (Page No. - 86)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     12.1 Cyberdyne
     12.2 Ekso Bionics Holdings
     12.3 Rewalk Robotics
     12.4 Bionik Laboratories
     12.5 Rex Bionics
     12.6 Parker Hannifin
     12.7 B-Temia
     12.8 Bioness
     12.9 Hocoma AG (A Subsidiary of DIH Technologies)
     12.10 Wearable Robotics
     12.11 Gogoa Mobility Robots
     12.12 Exoatlet

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 109)
     13.1 Insights From Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (69 Tables)

Table 1 Cost of Medical Exoskeletons
Table 2 Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 3 Medical Exoskeleton Hardware Market, By Type, 2016–2023 (USD Million)
Table 4 Medical Exoskeleton Hardware Market, By Region, 2016–2023 (USD Million)
Table 5 Sensors Market, By Region, 2016–2023 (USD Million)
Table 6 Actuators Market, By Region, 2016–2023 (USD Million)
Table 7 Power Sources Market, By Region, 2016–2023 (USD Million)
Table 8 Control Systems Market, By Region, 2016–2023 (USD Million)
Table 9 Other Hardware Components, By Region, 2016–2023 (USD Million)
Table 10 Medical Exoskeleton Software Market, By Region, 2016–2023 (USD Million)
Table 11 Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 12 Powered Exoskeleton Market, By Region, 2016–2023 (USD Million)
Table 13 Passive Exoskeleton Market, By Region, 2016–2023 (USD Million)
Table 14 Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 15 Stationary Medical Exoskeletons Market, By Region, 2016–2023 (USD Million)
Table 16 Mobile Medical Exoskeletons Market, By Region, 2016–2023 (USD Million)
Table 17 Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 18 Medical Exoskeleton Market, By Extremity, 2016–2023 (Units)
Table 19 Lower Extremity Medical Exoskeletons Market, By Region, 2016–2023 (USD Million)
Table 20 Upper Extremity Medical Exoskeletons Market, By Region, 2016–2023 (USD Million)
Table 21 Medical Exoskeleton Market, By Region, 2016–2023 (USD Million)
Table 22 Medical Exoskeleton Market, By Region, 2016–2023 (Units)
Table 23 North America: Medical Exoskeleton Market, By Country, 2016–2023 (USD Million)
Table 24 North America: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 25 North America: Medical Exoskeleton Hardware Market, By Type, 2016–2023 (USD Million)
Table 26 North America: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 27 North America: Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 28 North America: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 29 US: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 30 US: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 31 US : Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 32 US: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 33 Canada: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 34 Canada: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 35 Canada: Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 36 Canada: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 37 Europe: Medical Exoskeleton Market, By Country, 2016–2023 (USD Million)
Table 38 Europe: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 39 Europe: Medical Exoskeleton Hardware Market, By Type, 2016–2023 (USD Million)
Table 40 Europe: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 41 Europe: Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 42 Europe: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 43 UK: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 44 UK: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 45 UK: Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 46 UK: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 47 Germany: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 48 Germany: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 49 Germany: Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 50 Germany: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 51 France: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 52 France: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 53 France: Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 54 France: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 55 RoE: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 56 RoE: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 57 RoE: Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 58 RoE: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 59 Asia: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 60 Asia: Medical Exoskeleton Hardware Market, By Type, 2016–2023 (USD Million)
Table 61 Asia: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 62 Asia: Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 63 Asia: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 64 RoW: Medical Exoskeleton Market, By Component, 2016–2023 (USD Million)
Table 65 RoW: Medical Exoskeleton Hardware Market, By Type, 2016–2023 (USD Million)
Table 66 RoW: Medical Exoskeleton Market, By Type, 2016–2023 (USD Million)
Table 67 RoW: Medical Exoskeleton Market, By Mobility, 2016–2023 (USD Million)
Table 68 RoW: Medical Exoskeleton Market, By Extremity, 2016–2023 (USD Million)
Table 69 Market Ranking: Medical Exoskeleton Market (2017)


List of Figures (31 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Estimation: Bottom-Up Approach
Figure 4 Market Size: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Medical Exoskeleton Market, By Component, 2018–2023 (USD Million)
Figure 7 Medical Exoskeleton Market, By Type, 2018–2023 (USD Million)
Figure 8 Medical Exoskeleton Market, By Extremity, 2018-2023 (USD Million)
Figure 9 Medical Exoskeleton Market, By Mobility, 2018–2023 (USD Million)
Figure 10 Medical Exoskeleton Market: Geographical Snapshot
Figure 11 Increasing Demand for Effective Rehabilitation Approaches is Driving Market Growth
Figure 12 Hardware is Projected to Dominate the Medical Exoskeleton Market in 2018
Figure 13 Actuators to Hold the Largest Share of the Medical Exoskeleton Hardware Market in 2018
Figure 14 Upper Extremity Exoskeletons to Grow at the Highest CAGR From 2018 to 2023
Figure 15 Asia to Be the Fastest-Growing Regional Segment During the Forecast Period
Figure 16 Medical Exoskeleton Market: Drivers, Opportunities, and Challenges
Figure 17 Aging Population, By Region, 2015 vs 2030
Figure 18 Percentage of Disabled People in the Total Population of the US, 2011–2016
Figure 19 US: Percentage of Disabled People, By Age Group, 2016
Figure 20 Hardware Segment to Dominate the Medical Exoskeleton Market During the Forecast Period
Figure 21 Powered Exoskeleton Segment to Dominate the Market During the Forecast Period
Figure 22 Mobile Medical Exoskeletons to Dominate the Medical Exoskeleton Market During the Forecast Period
Figure 23 Lower Extremity Medical Exoskeletons Segment to Dominate the Medical Exoskeleton Market During the Forecast Period
Figure 24 North America: Medical Exoskeleton Market Snapshot
Figure 25 Europe: Medical Exoskeleton Market Snapshot
Figure 26 Key Players Adopted Organic and Inorganic Growth Strategies Between January 2015 and June 2018
Figure 27 Market Evolution Framework
Figure 28 Cyberdyne: Company Snapshot (2017)
Figure 29 Company Snapshot: Ekso Bionics (2017)
Figure 30 Company Snapshot: Rewalk Robotics (2017)
Figure 31 Company Snapshot: Parker Hannifin (2017)

The global medical exoskeleton market is projected to reach USD 571.6 million by 2023 from USD 116.7 million in 2018, at a CAGR of 37.4% during the forecast period. Factors such as the increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches and increasing insurance coverage for medical exoskeletons in several countries are driving the growth of the medical exoskeleton market. The report segments the market into component, type, mobility, extremity, and region.

By extremity, the market is segmented into lower extremity medical exoskeletons and upper extremity medical exoskeletons. The upper extremity segment is projected to grow at the highest CAGR during the forecast period. These exoskeletons are generally used in the rehabilitation of upper limb amputees and stroke and cerebral palsy patients.

The medical exoskeleton market is segmented on the basis of component, into hardware and software. The hardware segment is estimated to account for the largest market share in 2018. The large share of this segment can be attributed to the fact that a large number of parts such as sensors, actuators, power sources, and control systems are required to manufacture exoskeletons. Manufacturers are also adding upgraded and advanced hardware into the overall design to enhance the capability of medical exoskeletons, making them smarter and more interactive.

The medical exoskeleton market is segmented by type into powered and passive exoskeletons. In 2018, the powered exoskeleton segment is expected to dominate the market. This segment is also expected to grow at the highest CAGR during the forecast period. The presence of sensors and various controlling functions in powered exoskeletons to sense motion, tilt, and speed is the major factor driving the growth of powered medical exoskeletons.

Medical Exoskeleton Market

The market is dominated by North America, followed by Europe. Factors such the growing geriatric population, increasing demand for self-assist exoskeletons, high prevalence of stroke, and the growing number of spinal cord injuries (SCI) are driving market growth in this region. However, the high cost of medical exoskeletons may restrain the growth of the market to a certain extent.

Ekso Bionics Holdings, Inc. (US), ReWalk Robotics Ltd (Israel), Parker Hannifin Corp (US), Bionik Laboratories Corp (Canada), CYBERDYNE Inc. (Japan), Rex Bionics Ltd. (UK), B-TEMIA Inc. (Canada), Hocoma AG (A Subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), and ExoAtlet, O.O.O. (Russia)) are the key players operating in this market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo